Holt-Oram syndrome is a developmental disorder characterized by distinctive malformations of the bones of the thumbs and upper limbs and abnormalities of the heart. The syndrome shows a marked variability in phenotype, with radial ray defects ranging from minor thumb abnormality through to severe reduction defect or phocomelia. The cardiac manifestations of Holt-Oram syndrome are similarly varied, and patients can present with a variety of structural heart abnormalities, atrial septal defects and ventricular septal defects being the most common, or conduction defects evident on ECG profiles. The syndrome is estimated to occur in about 1 out of every 100,000 births. 60% of affected individuals have an affected parent. In about 40 percent of cases, the disorder is the result of a spontaneous genetic change.
The gene for Holt-Oram syndrome has been identified as TBX5 on chromosome 12q24. The TBX5 gene encodes a protein of 518 amino acids that belongs to the family of the T box transcriptional factors, and is expressed in embryonic heart and limb tissues, consistent with its involvement in development of the heart and skeletal structures. TBX5 contains a highly conserved DNA binding domain, the T box domain. TBX5 can bind to DNA and activate transcription of its target genes.